Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Borrmann 4Çü À§¾Ï ȯÀÚ¿¡¼­ Àå±â »ýÁ¸ÀÚÀÇ Æ¯¼º°ú ¿¹ÈÄÀÎÀÚ Clinicopathologic Characteristics and Prognostic Factors of Long-term Survivors of Borrmann Type 4 Gastric Cancer

´ëÇѼÒÈ­±âÇÐȸÁö 2003³â 41±Ç 1È£ p.9 ~ 14
·ùÁ¦È£, À°Á¤È¯, ±èº´½Ä, ¿À¼ºÅÂ, Á¤¼øÀç, ÃÖ¿ø¿ë,
¼Ò¼Ó »ó¼¼Á¤º¸
·ùÁ¦È£ ( Ryu Je-Ho ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç

À°Á¤È¯ ( Yook Jeong-Hwan ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç
±èº´½Ä ( Kim Byung-Sik ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç
¿À¼ºÅ ( Oh Sung-Tae ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç
Á¤¼øÀç ( Jung Soon-Tae ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç
ÃÖ¿ø¿ë ( Choi Won-Yong ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¿Ü°úÇб³½Ç

Abstract

¸ñÀû: 4Çü À§¾ÏÀº ¶Ñ·ÇÇÑ Á¾¾çÀÇ µ¹ÃâÀ̳ª ±Ë¾ç ¼Ò°ß¾øÀÌ ¾Ï¼¼Æ÷ÀÇ ¹Ì¸¸¼º ħÀ±°ú ±×·Î ÀÎÇÑ À§º®ÀÌ ºñÈĶó´Â Ư¡À» °¡Áö°í ÀÖ¾î ¿¹ÈÄ°¡ ³ª»Ú´Ù. 4Çü À§¾Ï ȯÀÚÀÇ »ýÁ¸À» Ç×¼§½ÃÅ°±â À§Çؼ­´Â Àå±â »ýÁ¸ÀÚÀÇ ÀÓ»óº´¸®ÇÐÀû Ư¡À» Á¤¸³ÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù. µû¶ó¼­ ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº º»¿ø¿¡¼­ °æÇèÇÑ 4Çü À§¾Ï ȯÀÚ Áß Àå±â »ýÁ¸ÀÚ¿Í ´Ü±â »ýÁ¸ÀÚÀÇ ÀÓ»óº´¸®ÇÐÀû Ư¡À» ºÐ¼®ÇÏ¿© ÀÌ·¯ÇÑ È¯ÀÚÀÇ ¿¹ÈÄ¿¡ ¿µÇâÀ» ³¢Ä¡´Â ÀÎÀÚ¸¦ ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.

´ë»ó ¹× ¹æ¹ý: 1989³â 7¿ùºÎÅÍ 1997³â 12¿ù±îÁö ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ
¼­¿ï¾Æ»êº´¿ø¿¡¼­ À§ÀýÁ¦¼úÀ» ½ÃÇà¹ÞÀº ȯÀÚ Áß 4Çü À§¾ÏÀ¸·Î Áø´Ü ¹ÞÀº 370¿¹¸¦ ´ë»óÀ¸·Î ¿Ü·¡±â·ÏÁö¿Í º´¸®°Ë»ç ±â·ÏÀ» ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿´´Ù. 4Çü ȯÀÚ ¹× ±ÙÄ¡Àû ÀýÁ¦¼úÀ» ½ÃÇà ¹ÞÀº 4Çü ȯÀÚÀÇ ÀÓ»óº´¸®ÇÐÀû Ư¡ Áß »ýÁ¸À²¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿¹ÈÄÀÎÀÚ¸¦ ºÐ¼®ÇÏ¿© µ¶¸³ÀûÀÎ ÀÎÀÚ°¡ ÀÖ´ÂÁö Á¶»çÇÏ¿´´Ù.

°á°ú: 4Çü ȯÀÚ 370¸íÀÇ 5³â »ýÁ¸À²Àº 21%¿´´Ù 4Çü À§¾ÏÀÇ ¿¹ÈÄ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀÎÀÚ¸¦ »ýÁ¸À²Àº ÅëÇÑ ´Üº¯·® ºÐ¼®À¸·Î Á¶»çÇØ º» ¹Ù Á¾¾çÀÇ À§Ä¡, Á¾¾çÀÇ Å©±â, À§º® ħ½ÀÁ¤µµ, ¸²ÇÁÀý ÀüÀÌ Á¤µµ, º´±â, º¹¸· ¹× °£ ÀüÀÌ, ±ÙÄ¡Àû ÀýÁ¦ ¿©ºÎ°¡ ÀÇÀÇ°¡ ÀÖ¾úÀ¸¸ç, ´Ùº¯·® ºÐ¼®¿¡¼­ Á¾¾çÀÇ À§Ä¡°¡ À¯ÀÇÇÑ µ¶¸³ ÀÎÀÚ¿´´Ù.

°á·Ð: 4Çü À§¾ÏÀÌ ¸¹Àº ºÎÀ§¸¦ ħ¹üÇÏ°í º´±â°¡ ÁøÇàµÈ »óÅ¿¡¼­ Áø´ÜµÇ°í º¹¸· ÀüÀÌ°¡ ºó¹øÇÏ°Ô ÀϾ´Â ¿¹ÈÄ°¡ ºÒ·®ÇÑ ¾ÏÀÏÁö¶óµµ, ±¹¼ÒºÎÀ§¸¦ Á¡°ÅÇÑ Å©±â°¡ ÀÛÀº 4Çü À§¾Ï¿¡¼­´Â ±ÙÄ¡ÀûÀýÁ¦¼úÀ» ½ÃÇàÇÔÀ¸·Î½á »ýÁ¸±â°£ÀÇ ¿¬ÀåÀ» ±â´ëÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î »ý°¢ÇÑ´Ù.

Background/Aims: Prognosis of Borrmann type 4 gastric cancer is still poor. To improve the prognosis of patients with Borrmann type 4 gastric cancer, it is important to understand the clinicopathological features of patients with a long-term survival. Thus, we compared the characteristics of the patients with a long-term survival (survival duration more than 5 years) with patients with a short-term survival.

Methods: We analyzed retrospectively 370 patients who were diagnosed as having Borrmann type 4 gastric cancer and underwent gastric resection between 1989 to 1997 at our hospital. Twenty-one percent of the patients survived longer than 5 years. For comparison of clinicopathlogical factors, the chi-square test was used and multivariate analysis was performed in order to focus on prognostic factors.

Results: The 5-year survival rate of the total 370 patients was 21%. Significant difference was noted in the following variables : location of tumor, size, peritoneal metastsis, hepatic metastasis, lymph node metastasis, depth of invasion, stage and curability. In multivariate analysis, the location of tumor was the most significant independent prognostic factor.

Conclusion: These results suggest that even in Borrmann type 4 gastric cancer, a localired disease can be cured by a radical resection.

Å°¿öµå

°æ¼º À§¾Ï;À§¾Ï;¿¹ÈÄ;Àå±â »ýÁ¸ÀÚ
Stomach neoplasms;Borrmann type 4;Prognosis;Long term survivors

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS